Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 5
2008 3
2009 1
2010 1
2011 2
2012 1
2014 2
2015 1
2016 1
2017 3
2018 2
2019 3
2020 4
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
The Innate Part of the Adaptive Immune System.
Hillion S, Arleevskaya MI, Blanco P, Bordron A, Brooks WH, Cesbron JY, Kaveri S, Vivier E, Renaudineau Y. Hillion S, et al. Among authors: bordron a. Clin Rev Allergy Immunol. 2020 Apr;58(2):151-154. doi: 10.1007/s12016-019-08740-1. Clin Rev Allergy Immunol. 2020. PMID: 31154567 Review.
Epigenetics in Primary Sjögren's Syndrome.
Bordron A, Devauchelle-Pensec V, Le Dantec C, Capdeville A, Brooks WH, Renaudineau Y. Bordron A, et al. Adv Exp Med Biol. 2020;1253:285-308. doi: 10.1007/978-981-15-3449-2_11. Adv Exp Med Biol. 2020. PMID: 32445100 Review.
Complement System: a Neglected Pathway in Immunotherapy.
Bordron A, Bagacean C, Tempescul A, Berthou C, Bettacchioli E, Hillion S, Renaudineau Y. Bordron A, et al. Clin Rev Allergy Immunol. 2020 Apr;58(2):155-171. doi: 10.1007/s12016-019-08741-0. Clin Rev Allergy Immunol. 2020. PMID: 31144209 Review.
JAK Inhibitors and Oxidative Stress Control.
Charras A, Arvaniti P, Le Dantec C, Dalekos GN, Zachou K, Bordron A, Renaudineau Y. Charras A, et al. Among authors: bordron a. Front Immunol. 2019 Dec 6;10:2814. doi: 10.3389/fimmu.2019.02814. eCollection 2019. Front Immunol. 2019. PMID: 31867003 Free PMC article.
Abnormal B cell glycosylation in autoimmunity: A new potential treatment strategy.
Morel M, Pochard P, Echchih W, Dueymes M, Bagacean C, Jousse-Joulin S, Devauchelle-Pensec V, Cornec D, Jamin C, Pers JO, Bordron A. Morel M, et al. Among authors: bordron a. Front Immunol. 2022 Aug 25;13:975963. doi: 10.3389/fimmu.2022.975963. eCollection 2022. Front Immunol. 2022. PMID: 36091064 Free PMC article.
Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
Bagacean C, Iuga CA, Bordron A, Tempescul A, Pralea IE, Bernard D, Cornen M, Bergot T, Le Dantec C, Brooks W, Saad H, Ianotto JC, Pers JO, Zdrenghea M, Berthou C, Renaudineau Y. Bagacean C, et al. Among authors: bordron a. J Leukoc Biol. 2022 Feb;111(2):313-325. doi: 10.1002/JLB.4HI0620-392R. Epub 2021 Jul 20. J Leukoc Biol. 2022. PMID: 34288092
17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia.
Bagacean C, Tempescul A, Ternant D, Banet A, Douet-Guilbert N, Bordron A, Bendaoud B, Saad H, Zdrenghea M, Berthou C, Paintaud G, Renaudineau Y. Bagacean C, et al. Among authors: bordron a. J Immunother Cancer. 2019 Jan 29;7(1):22. doi: 10.1186/s40425-019-0509-0. J Immunother Cancer. 2019. PMID: 30696487 Free PMC article.
34 results